David M. Hyman

2011–2022 年に発表

139
論文数
45,854
被引用数
87
h 指数
139
i10 指数

被引用数

David M. Hyman の年別被引用数1992 年: 被引用 3 件1998 年: 被引用 4 件1999 年: 被引用 1 件2000 年: 被引用 2 件2004 年: 被引用 4 件2007 年: 被引用 1 件2009 年: 被引用 2 件2011 年: 被引用 2 件2012 年: 被引用 2 件2013 年: 被引用 4 件2014 年: 被引用 13 件2015 年: 被引用 40 件2016 年: 被引用 112 件2017 年: 被引用 279 件2018 年: 被引用 620 件2019 年: 被引用 2,255 件2020 年: 被引用 3,501 件2021 年: 被引用 3,580 件2022 年: 被引用 2,922 件2023 年: 被引用 2,146 件2024 年: 被引用 3,054 件2025 年: 被引用 1,411 件2026 年: 被引用 48 件1993〜1997 年は被引用が無いため表示していません2001〜2003 年は被引用が無いため表示していません2005〜2006 年は被引用が無いため表示していません2008 年は被引用が無いため表示していません2010 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 6,849 件、この内訳の 27.7%中国: 引用元論文 2,847 件、この内訳の 11.5%イタリア: 引用元論文 1,418 件、この内訳の 5.7%イギリス: 引用元論文 1,393 件、この内訳の 5.6%ドイツ: 引用元論文 1,178 件、この内訳の 4.8%フランス: 引用元論文 1,019 件、この内訳の 4.1%スペイン: 引用元論文 902 件、この内訳の 3.6%日本: 引用元論文 878 件、この内訳の 3.5%カナダ: 引用元論文 804 件、この内訳の 3.3%オランダ: 引用元論文 642 件、この内訳の 2.6%オーストラリア: 引用元論文 597 件、この内訳の 2.4%スイス: 引用元論文 516 件、この内訳の 2.1%
0%27.7%その他 23.1%

分野

  • Medicine60.9%
  • Biochemistry, Genetics and Molecular Biology32.2%
  • Immunology and Microbiology2.1%
  • Computer Science1.3%
  • Engineering1%
  • Chemistry0.5%
  • その他2%

トピック

  • Cancer Genomics and Diagnostics8.1%
  • Lung Cancer Treatments and Mutations4.4%
  • Cancer Immunotherapy and Biomarkers3.9%
  • Genetic factors in colorectal cancer2.4%
  • Colorectal Cancer Treatments and Studies1.8%
  • Pancreatic and Hepatic Oncology Research1.8%
  • その他77.6%

共著者

全論文

検索で開く
  1. A view on drug resistance in cancer

    著者: , , - Nature 2019 被引用: 2,793

  2. OncoKB: A Precision Oncology Knowledge Base

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Antonio Omuro, Michael A. Postow, Dana E. Rathkopf, Alexander N. Shoushtari, Neerav Shukla, Martin H. Voss, Ederlinda Paraiso, Ahmet Zehir, Michael F. Berger, Barry S. Taylor, Leonard B. Saltz, Gregory J. Riely, Marc Ladanyi, David M. Hyman, José Baselga, Paul Sabbatini, David B. Solit, Nikolaus Schultz - JCO Precision Oncology 2017 被引用: 2,698

  3. Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Laetitia Borsu, Justyna Sadowska, Jacklyn Casanova, Ruben Bacares, Iwona Kiecka, Anna Razumova, Julie B Son, Lisa Stewart, Tessara Baldi, Kerry Mullaney, Hikmat Al‐Ahmadie, Efsevia Vakiani, Adam Abeshouse, Alexander Penson, Philip Jonsson, Niedzica Camacho, Matthew T. Chang, Helen Won, Benjamin Groß, Ritika Kundra, Zachary Heins, Hsiao‐Wei Chen, Sarah Phillips, Hongxin Zhang, Jiaojiao Wang, Angelica Ochoa, Jonathan Wills, Michael Eubank, Stacy B. Thomas, Stuart M. Gardos, Dalicia N. Reales, Jesse Galle, Robert Durany, Roy Cambria, Wassim Abida, Andrea Cercek, Darren R. Feldman, Mrinal M. Gounder, A. Ari Hakimi, James J. Harding, Gopa Iyer, Yelena Y. Janjigian, Emmet Jordan, Ciara M. Kelly, Maeve A. Lowery, Luc G.T. Morris, Antonio Omuro, Nitya Raj, Pedram Razavi, Alexander N. Shoushtari, Neerav Shukla, Tara E. Soumerai, Anna M. Varghese, Rona Yaeger, Jonathan Coleman, Bernard H. Bochner, Gregory J. Riely, Leonard B. Saltz, Howard I. Scher, Paul Sabbatini, Mark E. Robson, David S. Klimstra, Barry S. Taylor, José Baselga, Nikolaus Schultz, David M. Hyman, Maria E. Arcila, David B. Solit, Marc Ladanyi, Michael F. Berger - Nature Medicine 2017 被引用: 3,517

  4. AACR Project GENIE: Powering Precision Medicine through an International Consortium

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Walter Kinyua, Priti Kumari, Ritika Kundra, Marc Ladanyi, Céline Lefèbvre, Michele L. Lenoue-Newton, Eva M. Lepisto, Mia Levy, Neal I. Lindeman, James Lindsay, David Liu, Zhibin Lu, Laura E. MacConaill, Ian Maurer, David S. Maxwell, Gerrit A. Meijer, Funda Meric‐Bernstam, Christine Micheel, Clinton Miller, Gordon B. Mills, Nathanael D. Moore, Petra M. Nederlof, Larsson Omberg, John A. Orechia, Ben Ho Park, Trevor J. Pugh, Brendan Reardon, Barrett J. Rollins, Mark J. Routbort, Charles L. Sawyers, Deborah Schrag, Nikolaus Schultz, Kenna Shaw, Priyanka Shivdasani, Lillian L. Siu, David B. Solit, Gabe S. Sonke, Jean Charles Soria, Parin Sripakdeevong, Natalie Stickle, Thomas Stricker, Shawn M. Sweeney, Barry S. Taylor, Jelle J. ten Hoeve, Stacy B. Thomas, Eliezer M. Van Allen, Laura van ‘t Veer, Tony van de Velde, Harm van Tinteren, Victor E. Velculescu, Carl Virtanen, Emile E. Voest, Lucy Lu Wang, Chetna Wathoo, Stuart Watt, Celeste Yu, Thomas Yu, Emily Yu, Ahmet Zehir, Hongxin Zhang - Cancer Discovery 2017 被引用: 2,004

  5. Efficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and Children

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Brian B. Tuch, Kevin Ebata, Scott Cruickshank, Nora Ku, Michael C. Cox, Douglas S. Hawkins, David S. Hong, David M. Hyman - New England Journal of Medicine 2018 被引用: 2,728

  6. Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2020 被引用: 994

  7. Cancer therapy shapes the fitness landscape of clonal hematopoiesis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Konrad H. Stopsack, Barbara Spitzer, Simon Mantha, James A. Fagin, Laura Boucai, Christopher J. Gibson, Benjamin L. Ebert, Andrew L. Young, Todd E. Druley, Koichi Takahashi, Nancy Gillis, Markus Ball, Eric Padron, David M. Hyman, José Baselga, Larry Norton, Stuart M. Gardos, Virginia M. Klimek, Howard I. Scher, Dean F. Bajorin, Eder Paraiso, Ryma Benayed, Maria E. Arcila, Marc Ladanyi, David B. Solit, Michael F. Berger, Martin S. Tallman, Montserrat García‐Closas, Nilanjan Chatterjee, Luis A. Díaz, Ross L. Levine, Lindsay M. Morton, Ahmet Zehir, Elli Papaemmanuil - Nature Genetics 2020 被引用: 741

  8. The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nikolaus Schultz, Mark E. Robson, Clifford A. Hudis, Edi Brogi, Agnès Viale, Larry Norton, Maura N. Dickler, Michael F. Berger, Christine A. Iacobuzio–Donahue, Sarat Chandarlapaty, Maurizio Scaltriti, Jorge S. Reis‐Filho, David B. Solit, Barry S. Taylor, José Baselga - Cancer Cell 2018 被引用: 1,006

  9. Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical Outcomes

    著者: , , , , , , , , , , , , , , - Cell stem cell 2017 被引用: 855

  10. Small molecules, big impact: 20 years of targeted therapy in oncology

    著者: , , , - The Lancet 2020 被引用: 602

  11. Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations

    著者: , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2015 被引用: 1,734

  12. Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy

    著者: , , , , , , , , , , , , , , , , , , , - Science 2017 被引用: 1,185

  13. High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alexandra S. Heerdt, Marc Ladanyi, David M. Hyman, David R. Jones, Monica Morrow, Gregory J. Riely, Howard I. Scher, Charles M. Rudin, Mark E. Robson, Luis A. Díaz, David B. Solit, Alexander M. Aravanis, Jorge S. Reis‐Filho - Nature Medicine 2019 被引用: 767

  14. Clinical Sequencing Defines the Genomic Landscape of Metastatic Colorectal Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Cell 2018 被引用: 864

  15. Genome doubling shapes the evolution and prognosis of advanced cancers

    著者: , , , , , , , , , , , , , , , , , , , - Nature Genetics 2018 被引用: 692

  16. Prospective Genotyping of Hepatocellular Carcinoma: Clinical Implications of Next-Generation Sequencing for Matching Patients to Targeted and Immune Therapies

    著者: , , , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2018 被引用: 592

  17. Mechanisms of Resistance to Noncovalent Bruton’s Tyrosine Kinase Inhibitors

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , David M. Hyman, Iannis Aifantis, Anthony Mato, Justin Taylor, Omar Abdel-Wahab - New England Journal of Medicine 2022 被引用: 237

  18. HER kinase inhibition in patients with HER2- and HER3-mutant cancers

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alexander Drilon, James J. Harding, Gopa Iyer, Barry S. Taylor, Michael F. Berger, Richard E. Cutler, Feng Xu, Anna Butturini, Lisa D. Eli, Grace Mann, Cynthia Farrell, Alshad S. Lalani, Richard Bryce, Carlos L. Arteaga, Funda Meric‐Bernstam, José Baselga, David B. Solit - Nature 2018 被引用: 788

  19. Repotrectinib (TPX-0005) Is a Next-Generation ROS1/TRK/ALK Inhibitor That Potently Inhibits ROS1/TRK/ALK Solvent- Front Mutations

    著者: , , , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2018 被引用: 480

  20. HER2-Mediated Internalization of Cytotoxic Agents in ERBB2 Amplified or Mutant Lung Cancers

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Anuja Bhalkikar, Fabiola Cecchi, David M. Hyman, Jason S. Lewis, Darren J. Buonocore, Alan L. Ho, Vicky Makker, Jorge S. Reis‐Filho, Pedram Razavi, Maria E. Arcila, Mark G. Kris, John T. Poirier, Ronglai Shen, Junji Tsurutani, Gary A. Ulaner, Elisa de Stanchina, Neal Rosen, Charles M. Rudin, Maurizio Scaltriti - Cancer Discovery 2020 被引用: 289

  21. Comprehensive Molecular Profiling of Intrahepatic and Extrahepatic Cholangiocarcinomas: Potential Targets for Intervention

    著者: , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2018 被引用: 578

  22. Ado-Trastuzumab Emtansine for Patients With HER2-Mutant Lung Cancers: Results From a Phase II Basket Trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2018 被引用: 559

  23. Prospective Genomic Profiling of Prostate Cancer Across Disease States Reveals Germline and Somatic Alterations That May Affect Clinical Decision Making

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Barry S. Taylor, Marc Ladanyi, Diana Mandelker, Liying Zhang, Victor E. Reuter, Philip W. Kantoff, David B. Solit, Michael F. Berger, Charles L. Sawyers, Nikolaus Schultz, Howard I. Scher - JCO Precision Oncology 2017 被引用: 531

  24. Microsatellite Instability Is Associated With the Presence of Lynch Syndrome Pan-Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Martin R. Weiser, Julio García Aguilar, David S. Klimstra, Luis A. Díaz, José Baselga, Liying Zhang, Marc Ladanyi, David M. Hyman, David B. Solit, Mark E. Robson, Barry S. Taylor, Kenneth Offit, Michael F. Berger, Zsofia K. Stadler - Journal of Clinical Oncology 2018 被引用: 627